https://ift.tt/eA8V8J
Rohtak, November 18
India is going to be amongst the pioneering nations of the world with the development of its indigenous Covid vaccine Covaxin in the near future. Indian Covid-19 vaccine is unique as it has shown minimum side-effects.
This was stated by Dr OP Kalra, Vice Chancellor of Pt Bhagwat Dayal Sharma University of Health Sciences, Rohtak, while addressing a news conference here today.
Professor Kalra disclosed that the third phase of the clinical human trials of Covaxin would begin at the Rohtak PGIMS on November 19. — TNS
from The Tribune https://ift.tt/3pHAdOk
via IFTTT
No comments:
Post a Comment